- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT07603934
The Effect of Different Intra-canal Medications on Postoperative Pain
Evaluation of Postoperative Pain After Using Ibuprofen, Nitrofurantoin, or Calcium Hydroxide as Intracanal Medicaments in Root Canal Treatment of Necrotic Mandibular Posterior Teeth. A Randomized Controlled Trial
The aim of this study is to assess the effect of ibuprofen, nitrofurantoin, and calcium hydroxide on postoperative pain after endodontic treatment of necrotic mandibular posterior teeth
Research question/hypothesis:
In patients with necrotic pulps in their mandibular posterior teeth, there would be no difference in the incidence and/or severity of postoperative pain after the use of ibuprofen, nitrofurantoin, or calcium hydroxide intracanal medications.
The study will evaluate postoperative pain after using either of the tested drugs as an intracanal medication amidst visits. of endodontic treatment in cases where pulp necrosis is confirmed.
Aperçu de l'étude
Statut
Les conditions
Intervention / Traitement
Description détaillée
Trial design:
- A Randomized controlled, double-blind, parallel-arm, clinical trial.
- Allocation ratio 1:1:1
- Framework: superiority
- Study settings:
Outpatient clinic of Endodontics at the Faculty of Dentistry, Egyptian Russian University, Badr city, Cairo governorate, Egypt.
Eligibility criteria
Inclusion criteria:
- Patients with necrotic pulps.
- Adult, healthy patients, older than 18 years old
- Males and females.
- Patient with the ability to understand and use pain scales.
- Patient who accepts enroll to the study.
Exclusion criteria:
- Patients' allergies or any other contraindication to any of the medications used.
- Pregnant and lactating females.
- Patients have been taking pain medication 12 hours earlier.
- Patients who have more than one symptomatic mandibular tooth in the same quadrant.
- Patients with contributory medical history (ASA>II).
- Diagnosis:
The diagnosis of pulp necrosis is confirmed through the patients' history, lack of response to cold testing and negative response to electric pulp tester whenever .The treatment will be done on two- visits.
• Treatment procedure: Each patient will be given an NRS chart to rate her /his presenting pain as preoperative pain. After complete mechanical preparation, each patient will be randomly assigned to either of three groups as follows, group 1: ibuprofen will be used as an intracanal medication, group 2: nitrofurantoin will be used as an intra canal medication and group 3: CaOH will be used as an intracanal medicament. The access cavity will be then sealed with temporary filling (MD-TEMP, META BIOMED CO., LTD. Chungbuuk, Korea). Post-operative instructions and appropriate post-operative rescue medication will be prescribed (400mg Ibuprofen). All patients will be asked to record their postoperative pain level felt on NRS at 6, 12, 24, 48, 72 hours and 7 days.
One week after the first visit, patients will be recalled to the clinic to complete their root canal treatment as recommended. All canals will be dried then obturated by the modified single cone technique using 0.04 taper gutta percha points and epoxy resin sealer. Patients will be referred to an operative or a fixed prosthodontics specialist for crown placement at the Faculty of Dentistry, Egyptian Russian University.
Research objective (state the aim) The aim of this study is to assess the effect of ibuprofen, nitrofurantoin and calcium hydroxide on postoperative pain after endodontic treatment of necrotic mandibular posterior teeth.
Sample size: (if calculation equation is used please state) A total of 111 patients, 37 per group needed for the clinical trial was calculated
Grouping & Randomization used:(specify if present) Three groups Group 1: ibuprofen Group 2: nitrofurantoin Group 3: calcium hydroxide
Outcome variables:
The primary outcome the effect of ibuprofen, nitrofurantoin and calcium hydroxide on postoperative pain after endodontic treatment of necrotic mandibular posterior teeth.
Postoperative pain will be measured using NRS at 6, 12, 24, 48, 72 hours postoperatively. Numerical Rating Scale (NRS) (20): It is an 11-point scale consisting of numbers from 0 through 10; - 0 reading represents "no pain" - 1-3 readings represent "mild pain" - 4- 6 readings represent "moderate pain" - 7- 10 readings represent "severe pain"
Type d'étude
Inscription (Estimé)
Phase
- Première phase 1
Contacts et emplacements
Lieux d'étude
-
-
Cairo Governorate
-
Cairo, Cairo Governorate, Egypte, 4450113
- Recrutement
- Faculty of Oral and Dental Medicine, Egyptian Russian University
-
Contact:
- E-mail: maha-nasrmorsi@eru.edu.eg
-
Chercheur principal:
- Maha Nasr, Assistant Professor
-
Contact:
- Maha Nasr, Assistant professor
- Numéro de téléphone: 01114367063
- E-mail: mahmouhaa87@gmail.com
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
- Adulte
Accepte les volontaires sains
La description
Inclusion Criteria:
- Patients with necrotic pulps.
- Adult, healthy patients, older than 18 years old
- Males and females.
- Patient with the ability to understand and use pain scales.
- Patient who accepts enroll to the study.
Exclusion Criteria:
- Patients' allergies or any other contraindication to any of the medications used.
- Pregnant and lactating females.
- Patients have been taking pain medication 12 hours earlier.
- Patients who have more than one symptomatic mandibular tooth in the same quadrant.
- Patients with contributory medical history (ASA>II).
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Traitement
- Répartition: Randomisé
- Modèle interventionnel: Affectation parallèle
- Masquage: Double
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Expérimental: ibuprofen
Ibuprofen.
a NSAID, will be ground and formed into a paste to be placed inside the root canals of necrotic mandibular posterior teeth, to explore its effects on post-operative pain
|
Ibuprofen.
a NSAID, will be ground and formed into a paste to be placed inside the root canals of necrotic mandibular posterior teeth, to explore its effects on post-operative pain
|
|
Expérimental: nitrofurantoin
|
Nitrofurantoin tablets will be formed into a paste to be placed inside the root canals of necrotic mandibular premolars during endodontic treatment.
|
|
Comparateur actif: calcium hydroxide
|
Calcium Hydroxide intracanal medicament will be placed inside the root canals of mandibular necrotic posterior teeth during endodontic treatment.
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Intensity of Postoperative pain
Délai: Baseline (preoperative) and at 6, 12, 24, 48 and 72 hours after placement of the intracanal medicament.
|
Postoperative pain intensity will be self-reported by patients using an 11-point Numerical rating scale (NRS), where 0 represents "no paon" and 10 represents "the worst immaginable pain"
|
Baseline (preoperative) and at 6, 12, 24, 48 and 72 hours after placement of the intracanal medicament.
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Incidence of Postoperative pain
Délai: Up to 72 hours after placement of intracanal medicament
|
The percentage of patients experiencing any postoperative pain (NRS=0) within the follow-up period
|
Up to 72 hours after placement of intracanal medicament
|
|
Postoperative Analgesic Consumption
Délai: Up to 72 hours postoperatively
|
The total amount of prescribed analgesics consumed by the oatient.
this will be measured by counting the total number of Ibuprofen 400 mg tablets taken by patients.
|
Up to 72 hours postoperatively
|
Collaborateurs et enquêteurs
Parrainer
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Réel)
Achèvement primaire (Estimé)
Achèvement de l'étude (Estimé)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Mots clés
Termes MeSH pertinents supplémentaires
- Maladies parodontales
- Maladies de la bouche
- Maladies stomatognathiques
- Processus pathologiques
- Maladies périapicales
- Maladies de la mâchoire
- Maladies de la pulpe dentaire
- Maladies dentaires
- Nécrose
- Parodontite
- Conditions pathologiques, signes et symptômes
- Parodontite périapicale
- Nécrose de la pulpe dentaire
- Produits chimiques organiques
- Composés hétérocycliques, 1 anneau
- Composés hétérocycliques
- Acides carboxyliques
- Produits chimiques inorganiques
- Anions
- Ions
- Électrolytes
- Hydroxydes
- Alcalies
- Acides, carbocyclique
- Composés nitro
- Phénylpropionates
- Composés calciques
- Furannes
- Nitrofurans
- Ibuprofène
- Nitrofurantoïne
- Hydroxyde de calcium
Autres numéros d'identification d'étude
- ERU2
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
produit fabriqué et exporté des États-Unis.
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .